Protein

and albumin were measured in spot urine samples and expressed as a ratio to creatinine in mg/mmol. uAPR was determined by dividing uACR by uPCR. eGFR was calculated using the four-variable Modification of Diet in Renal Disease (MDRD) equation [23]. The significance of low-level proteinuria (uPCR < 30 mg/mmol) is currently unknown, so we focussed further on proteinuric samples (uPCR ≥ 30 mg/mmol, equivalent to ∼300 mg/day of urinary protein). Those proteinuric samples for which a uAPR could be calculated were categorized into two classes according to the calculated uAPR: predominantly tubular proteinuria (TP): uPCR ≥ 30 mg/mmol and uAPR ≤ 0.4; predominantly glomerular proteinuria (GP): uPCR ≥ 30 mg/mmol and uAPR > 0.4. The rationale for this assumption is detailed in our recent publication selleck chemical [22], but briefly we examined routine samples submitted for high-resolution protein electrophoresis, which had a uPCR and uACR performed concurrently. Idelalisib A characteristic pattern of bands was identified at electrophoresis. This was classified as predominantly GP if there were strong bands for albumin, α1-acid glycoprotein and α1-antitrypsin

in a broad α1-zone and transferrin (β1). The pattern was classified as predominantly TP if there was a relatively faint albumin band, a double band in the α2 region attributable to α2-microglobulin, a strong band in the mid-beta region attributable to β2-microglobulin, and diffuse staining in the gamma region attributable to free light chains. ‘Mixed’ patterns were seen in a few patients with CKD. A uAPR of < 0.4 was found to be 88% sensitive and 99% specific for the diagnosis of primary tubulointerstitial disorders on renal biopsy [22]. We looked at the TP and GP groups and excluded duplicate values by excluding those with an incomplete data set at sampling first and then selected the data point with the highest uPCR for each patient. In general there was little difference between the retained and the excluded values. Patients with heavy proteinuria as assessed by uPCR (uPCR > 100 mg/mmol ≅1 g/day) were further Amylase assessed by a nephrologist. The causes of renal disease in these patients were identified

using hospital notes, imaging and results (including renal biopsy results where available). The percentage of samples with significant proteinuria (uPCR ≥ 30 mg/mmol) was calculated. To assess for potential bias, samples with a paired uPCR and uACR measurement were compared with those with a uPCR measurement only. Differences between groups were assessed using an independent samples t-test for normally distributed continuous variables, a Mann–Whitney U-test for nonparametric variables and a χ2 test for categorical variables. P < 0.05 denotes statistical significance. The statistical analysis was performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). There were 5244 uPCR results available for 1378 patients (median three values).